640 episodes

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.

Squawk Pod CNBC

    • Business
    • 4.2 • 336 Ratings

Squawk Pod is a daily, guided curation of the top moments and takeaways from CNBC’s flagship morning show, “Squawk Box”, anchored by Joe Kernen, Becky Quick and Andrew Ross Sorkin. Each day, the podcast includes news making interviews, perspective and analysis from iconic guest hosts, and slices of debate and discussion—from the heated to the hilarious— all wrapped with exclusive context and color from Senior Producer Katie Kramer.

    Variant Preparedness, Reports from Beijing, & Debt Drama

    Variant Preparedness, Reports from Beijing, & Debt Drama

    As the international business community responds to China’s treatment of Peng Shuai, CNBC’s Eunice Yoon gives more details from Beijing and Yale School of Management’s Jeffrey Sonnenfeld discusses how leaders could and should be supporting the tennis Olympian. As cases of the omicron variant pop up in New York, Minnesota, and Colorado, questions arise about effective vaccination manufacturing and overall preparedness for yet another Covid wave. Plus, Ylan Mui reports on the debt ceiling drama in DC and a new plan from lawmakers as the Treasury rapidly approaches its last day of cash.

    In this episode:
    Jeffrey Sonnenfeld, @JeffSonnenfeld
    Eunice Yoon, @onlyyoontv
    Ylan Mui, @ylanmui
    Joe Kernen, @JoeSquawk
    Becky Quick, @BeckyQuick
    Andrew Ross Sorkin, @andrewrsorkin
    Cameron Costa, @CameronCostaNY

    • 26 min
    Grab-ing the Biggest SPAC; Supporting Peng Shuai

    Grab-ing the Biggest SPAC; Supporting Peng Shuai

    The omicron variant lands in the United States with its first known case appearing in California. The White House is out with new guidance on how to deal with the new variant by tightening travel restrictions, extending mask mandates, and rapid tests that may be costing consumers. Joe Kernen, Becky Quick, and Andrew Ross Sorkin discuss how this news might be influencing investors and the Fed. And the largest Southeast Asian company to list in the U.S. has gone public on the Nasdaq. SoftBank-backed “super app” Grab debuted in the largest SPAC merger of all time. Grab CEO & Founder Anthony Tan discusses the size of the company’s market. Plus, the Women’s Tennis Association announced they will boycott tournaments in China to protect the safety of their players, a move in support of Peng Shuai.
    In this episode:
    Anthony Tan, @AnthonyPY_Tan
    Joe Kernen, @JoeSquawk
    Becky Quick, @BeckyQuick
    Andrew Ross Sorkin, @andrewrsorkin
    Katie Kramer, @Kramer_Katie

    • 31 min
    Tapering “Transitory” & Merck’s Pill Approval

    Tapering “Transitory” & Merck’s Pill Approval

    The markets are reacting to comments from Fed Chair Jerome Powell, who announced a plan to taper its asset purchases faster. He--and the rest of the economist community--is ready to retire the word “transitory,” but his comments have not retired questions and concerns from investors. CNBC’s Steve Liesman explains Powell’s comments. CEO of Lazard’s Financial Advisory business Peter Orszag discusses Fed leadership and Lazard’s efforts to quantify climate issues in the equities market. The FDA has narrowly endorsed Merck’s oral Covid treatment pill; former FDA Commissioner Dr. Scott Gottlieb discusses therapeutics, vaccine efficacy against the omicron variant, and Covid-19’s evolution. Plus, how much do you love Tesla? Enough for a tattoo?

    In this episode:
    Dr. Scott Gottlieb, @ScottGottliebMD
    Peter Orszag, @porszag
    Steve Liesman, @SteveLiesman
    Joe Kernen, @JoeSquawk
    Becky Quick, @BeckyQuick
    Andrew Ross Sorkin, @andrewrsorkin
    Katie Kramer, @Kramer_Katie

    • 39 min
    Bridgewater’s Ray Dalio & NFTs for Good with Bill Tai

    Bridgewater’s Ray Dalio & NFTs for Good with Bill Tai

    Bridgewater Associates’ Ray Dalio holds firm in his belief that cash is not king, despite the market volatility triggered by the Covid omicron variant. Dalio discusses competing with China, the global economy, and his new book, “The Changing World Order.” Comments about omicron from Moderna CEO Stephane Bancel have spooked investors, and Jack Dorsey’s decision to step down from his role as Twitter CEO took the markets by surprise. Plus, for Giving Tuesday: a conversation about the potential for NFTs to innnovate philanthropy with venture capitalist, crypto optimist, blockchain backer and kite surfer Bill Tai. Founder of Metagood and one of the first to make an NFT for charity, Tai discusses paths forward for the metaverse and tech’s opportunity to impact positive change.

    In this episode:
    Ray Dalio, @RayDalio
    Bill Tai, @KiteVC
    Joe Kernen, @JoeSquawk
    Becky Quick, @BeckyQuick
    Andrew Ross Sorkin, @andrewrsorkin
    Cameron Costa, @CameronCostaNY

    • 40 min
    Pfizer CEO & Taking on Omicron

    Pfizer CEO & Taking on Omicron

    Pfizer CEO Albert Bourla says he’s “very, very confident” that the company’s Covid-19 treatment pill will be effective against the omicron variant of Covid-19, and that Pfizer will be able to manufacture a vaccine for this variant within 100 days, to be used if necessary. Pfizer submitted its application earlier this month to the Food and Drug Administration to authorize the pill, Paxlovid, for emergency use. Bourla spoke with CNBC’s Meg Tirrell and the ‘Squawk Box’ team to discuss managing the new variant. Plus, oil prices jumped today as traders bet that Friday’s sharp sell-off was overdone. CNBC’s Brian Sullivan reports on how the omicron Covid variant concerns are impacting energy markets.

    In this episode:
    Albert Bourla, @AlbertBourla
    Brian Sullivan, @SullyCNBC
    Joe Kernen, @JoeSquawk
    Becky Quick, @BeckyQuick
    Andrew Ross Sorkin, @andrewrsorkin
    Katie Kramer, @Kramer_Katie

    • 30 min
    The New Variant: “It’s Still Early Days”

    The New Variant: “It’s Still Early Days”

    The World Health Organization will meet today to discuss a new heavily-mutated variant of Covid-19. The variant has been detected in small numbers in South Africa, with reports of cases in Israel and Hong Kong. CNBC’s Meg Tirrell reports on how Covid-19 drugmakers like Moderna and Pfizer are responding to the variant. Dr. Kavita Patel, former White House health policy director and fellow at the Brookings Institution, also reacts to the new variant but says we shouldn’t “get ahead of ourselves” just yet. NBC’s Raf Sanchez reports from Tel Aviv that Israel has barred travel to several southern African nations over the new variant, as well as Singapore and several other nations. The U.K. immediately moved to ban flights from South Africa, Lesotho, Botswana, Namibia, Eswatini and Zimbabwe. Plus, Priceline CEO Brett Keller discusses holiday travel demand, and how the coronavirus variant could impact bookings.

    In this episode:
    Kavita Patel, @kavitapmd
    Meg Tirrell, @megtirrell
    Brett Keller, @priceline
    Raf Sanchez, @rafsanchez
    Becky Quick, @BeckyQuick
    Andrew Ross Sorkin, @andrewrsorkin
    Cameron Costa, @CameronCostaNY

    • 22 min

Customer Reviews

4.2 out of 5
336 Ratings

336 Ratings

lee_j54 ,

Refreshing

Great discourse and variety of opinions. Hosts are each great journalists, and I appreciate their willingness to try to understand views different from their own. They don’t always have all the answers, nor do they pretend to. Others could learn from them.

SN Chowdary ,

Addictive

Great show, very casual with lot of information. Great hosts.

Tjjjjtj ,

Joe ruins it

I used to like this but Joe gets worse and worse, just wasting time, being disruptive, being reactionary. Joe used to be conservative but interesting now he’s just a reactionary old bore and I can’t listen or watch anymore.

Top Podcasts In Business

You Might Also Like

More by CNBC